A phase II study of sunitinib in recurrent or metastatic endometrial carcinoma: A trial of the PMH Phase II Consortium

被引：0
|
作者：
Welch, S. [1 ,2 ,3 ,4 ,5 ]
Mackay, H. J. [1 ,2 ,3 ,4 ,5 ]
Hirte, H. [1 ,2 ,3 ,4 ,5 ]
Fleming, G. F. [1 ,2 ,3 ,4 ,5 ]
Morgan, R. [1 ,2 ,3 ,4 ,5 ]
Wang, L. [1 ,2 ,3 ,4 ,5 ]
Blattler, C. [1 ,2 ,3 ,4 ,5 ]
Ivy, S. P. [1 ,2 ,3 ,4 ,5 ]
Oza, A. M. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Princess Margaret Hosp, Phase II Consortium, Toronto, ON M4X 1K9, Canada
[2] Juravinski Canc Ctr, Hamilton, ON, Canada
[3] Univ Chicago Consortium, Chicago, IL USA
[4] Calif Canc Consortium, Duarte, CA USA
[5] Natl Canc Inst, Rockville, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5576
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A phase II trial of perifosine as second line therapy for advanced pancreatic cancer. A study of the Princess Margaret Hospital [PMH] phase II consortium.
    Hedley, D
    Moore, MJ
    Hirte, H
    Siu, L
    Vincent, M
    Jonker, D
    Mwang, H
    Nagai, J
    Dancey, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 349S - 349S
  • [42] Phase II study of sunitinib in patients with recurrent and/or metastatic squamous head and neck carcinoma: The GORTEC 2006-01 study
    Machiels, J. H.
    Henry, S.
    Zanetta, S.
    Kaminsky, M.
    Michoux, N.
    Bompas, E.
    Dillies, A.
    Faivre, S.
    Schmitz, S.
    Guigay, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Exemestane in advanced and recurrent endometrial carcinoma. A phase II study.
    Nordstrom, B.
    Salmi, T.
    Mirza, M.
    Abeler, V.
    Kristensen, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 266S - 266S
  • [44] A phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.
    Slomovitz, B. M.
    Brown, J.
    Johnston, T. A.
    Mura, D.
    Levenback, C.
    Wolf, J.
    Adler, K. R.
    Lu, K. H.
    Coleman, R. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Phase II Study of Sunitinib in Patients With Metastatic Urothelial Cancer
    Gallagher, David J.
    Milowsky, Matthew I.
    Gerst, Scott R.
    Ishill, Nicole
    Riches, Jamie
    Regazzi, Ashley
    Boyle, Mary G.
    Trout, Alisa
    Flaherty, Anne-Marie
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) : 1373 - 1379
  • [46] Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
    Oza, Amit M.
    Elit, Laurie
    Tsao, Ming-Sound
    Kamel-Reid, Suzanne
    Biagi, Jim
    Provencher, Diane Michele
    Gotlieb, Walter H.
    Hoskins, Paul J.
    Ghatage, Prafull
    Tonkin, Katia S.
    Mackay, Helen J.
    Mazurka, John
    Sederias, Joana
    Ivy, Percy
    Dancey, Janet E.
    Eisenhauer, Elizabeth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3278 - 3285
  • [47] Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)
    Post, C. C. B.
    Westermann, A. M.
    Boere, I. A.
    Witteveen, P. O.
    Ottevanger, P. B.
    Sonke, G. S.
    Lalisang, R., I
    Putter, H.
    Kranenbarg, E. Meershoek-Klein
    Braak, J. P. B. M.
    Creutzberg, C. L.
    Bosse, T.
    Kroep, J. R.
    GYNECOLOGIC ONCOLOGY, 2022, 165 (02) : 223 - 229
  • [48] Phase II trial of nintedanib in patients with recurrent or metastatic salivary gland cancer: A multicenter phase II study.
    Kim, Youjin
    Lee, Su Jin
    Park, Keunchil
    Lee, Se-hoon
    Sun, Jong Mu
    Keam, Bhumsuk
    An, Ho Jung
    Cho, Jae Yong
    Kim, Jin-Soo
    Lee, Ha-young
    Kim, HyeRyun
    Lee, Kyoung Eun
    Choi, Moon Young
    Lee, Ki Hyeong
    Ahn, Myung-Ju
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCICIND-148
    Oza, Amit M.
    Eisenhauer, Elizabeth A.
    Elit, Laurie
    Cutz, Jean-Claude
    Sakurada, Akira
    Tsao, Ming S.
    Hoskins, Paul J.
    Biagi, Jim
    Ghatage, Prafull
    Mazurka, John
    Provencher, Diane
    Dore, Naomi
    Dancey, Janet
    Fyles, Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) : 4319 - 4325
  • [50] A phase II study of pembrolizumab in combination with doxorubicin in advanced, recurrent or metastatic endometrial cancer
    Oaknin, A.
    Rubio Perez, M. J.
    Farinas Madrid, L.
    Redondo, A.
    Yubero Esteban, A.
    Gil Martin, M.
    Gonzalez Martin, A.
    Romero, I.
    Garcia-Donas, J.
    Serrano, R.
    Gallego Martinez, A.
    Ocariz Diez, M.
    Sanchez Lorenzo, M. L.
    Lopez Olmedo, M. D. Fenor De La Maza
    Rodriguez Freixinos, V.
    Piulats Rodriguez, J. M.
    ANNALS OF ONCOLOGY, 2019, 30
12345